The Gross Margin of Hybio Pharmaceutical Co Ltd (300199.SZ) is 52.73%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 52.73% |
| 2023-12-31 | 40.71% |
| 2022-12-31 | 72.85% |
| 2021-12-31 | 68.08% |
| 2020-12-31 | 79.17% |
| 2019-12-31 | 78.77% |
| 2018-12-31 | 85.42% |
| 2017-12-31 | 84.19% |
| 2016-12-31 | 80.14% |
| 2015-12-31 | 80.89% |